Global Stem Cells Market Analysis, Drivers, Restraints, Opportunities, Trends, Applications, and Growth Forecast: 2018 to 2029

“Global Stem Cells Market” is an upcoming report by MarketResearch.biz. The study and analysis will be conducted using expert opinions and inputs, as well as thorough primary and secondary research efforts to ascertain various aspects of the global stem cell market. Apart from revenues for global, regional, and country-wise segments, market revenue segmentation will be anthologized in a fastidious manner for clear understanding and flow. The global stem cell market report will be segmented on the basis of product, application, technology, therapy as well as region and countries.

Overview:

Stem cells are special human cells that have the ability to develop into several different types of cell types, from brain cells to muscle cells and can be used to repair damaged tissue in some cases. Whereas, stem cell therapy, also known as regenerative medicine, is the use of stem cells to prevent or treat a disease or condition.

Dynamics:

The success of regenerative medicine and an exponential increase in stem cell-based research are factors that are expected to fuel revenue growth of the global stem cell market in the coming years. Due to the high incidence of infections, the demand, awareness and on-going R&D for the development of vaccines as well as the increase in the demand for regenerative medicines are other factors that are projected to increase revenue growth of the global stem cells market.

In terms of product market segmentation, the adult stem cells segment is expected to account for the highest revenue share of the market due to the low risk factors associated with human body compatibility, sub-culturing, and the minimal need for production labor. The iPS segment is projected to register the fastest rate of growth over the next 10 years due to its potential to progress clinical research and the development of advanced drugs. The implementation of iPs cells to explore the genetic link between patients and diseases for new drug discoveries is projected to positively influence the revenue growth of this segment.

With regard to application, the regenerative medicine segment accounted for the largest market revenue share in 2019 due to the ongoing development and the increasing adoption of personalized medicine and companion diagnostics for oncological treatments as well as for other chronic diseases.

In 2019, neurology was the highest revenue producing regenerative medicine segment due to the significant presence of FDA-approved products. The applicability of regenerative medicine in the treatment of Alzheimer’s, Parkinson’s, among other neurodegenerative disorders is projected to fuel this segment’s revenue growth. The drug discovery & development segment is expected to register the fastest CAGR over the years to come due to the ease of providing an accurate and less expensive drug testing process.

With respect to technology, the cell acquisition technology segment accounted for the largest revenue share in 2019 and is expected to continue to do so in the foreseeable future. Bone marrow harvest is a common example of an implemented methodology used in the acquisition of stem cells. The cell production segment is expected to grow substantially due to the introduction of novel kits and reagents to optimize the production of stem cells.

Regarding therapy, the allogenic therapy segment accounted for the largest revenue share in 2019 and is expected to continue to do so over the foreseeable future. The autologous therapy segment is projected to grow expeditiously due to the low-risk complications associated with this form of treatment.

Regional Analysis:

The market in North America accounted for the largest revenue share of the global stem cells market in 2019 owing to high R&D investments in cytological research. Other factors contributing to this are extensive government funding and the presence of major biotechnological companies in this region. The Asia Pacific market is projected to grow at an exponential pace owing to a large patient population and strong cell-based therapy product pipelines.

Global Market Segmentation:

By Product:

• Adult Stem Cells (ASCs)
  • Neuronal ASCs
  • Hematopoietic ASCs
  • Mesenchymal ASCs
  • Umbilical Cord ASCs
  • Dental ASCs
  • Adipose‐derived ASCs
  • Dedifferentiated fat (DFAT) Cells
  • Other ASCs
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells 

By Application:

• Regenerative Medicine
  • Neurology
  • Orthopaedics
  • Oncology
  • Haematology
  • Cardiovascular and Myocardial Infraction
  • Injuries
  • Diabetes
  • Liver Disorder
  • Incontinence
  • Others
• Drug Discovery and Development 

By Technology:

• Cell Acquisition
  • Bone Marrow Harvest
  • Umbilical Blood Cord
  • Apheresis
• Cell Production
  • Therapeutic Cloning
  • In-vitro Fertilization
  • Cell Culture
  • Isolation
• Cryopreservation
• Expansion and Sub-Culture 

By Therapy:

• Autologous
• Allogenic 

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Celgene Corporation
• STEMCELL Technologies Inc.
• BIOTIME INC.
• Osiris Therapeutics Inc.
• Human Longevity Inc.
• Cynata
• Cytori Therapeutics
• Advanced Cell Technology Inc.
• Promethera Biosciences
• Mesoblast